BCL2 and cancer: From these three groups, the BAX (pro-apoptotic) and Bcl-2, Bcl-xL or Mcl1 (anti-apoptotic) proteins have gained the most attention over the recent decades, based on their deregulated expression, significance in the development of a number of cancers and their responsiveness to therapeutics [5].